A closer look at the technologies used by Airfinity
Airfinity
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
71-75 Shelton Street, London, Greater Lo...Phone Number
+44 9502389Website
www.airfinity.comRevenue
$25.2 MillionIndustry
About Airfinity
Airfinity is an independent predictive analytics company specializing in AI-enabled health analytics and forecasting for the life sciences ecosystem. Their products, including FRIDA for respiratory infectious disease forecasting and One ID for infectious disease intelligence, support decision-making for pharma, governments, and healthcare authorities. By providing real-time insights and predictive analytics, Airfinity helps clients act faster, reduce costs, and improve health outcomes. Their expertise spans infectious diseases, cardiometabolic conditions, and other chronic diseases, making them a trusted partner in the healthcare sector.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Airfinity
Compare insights from companies similar to Airfinity, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Airfinity
$25.2M
51-200
Private
-
2015
N/A
Airfinity Tech Stack
Top Business Services Companies
Frequently Asked Questions Regarding Airfinity
Sign Up For FreeTo access detailed company insights
Airfinity is an independent predictive analytics company specializing in AI-enabled health analytics and forecasting for the life sciences ecosystem. Their products, including FRIDA for respiratory infectious disease forecasting and One ID for infectious disease intelligence, support decision-making for pharma, governments, and healthcare authoriti... Read More
